A double antibody sandwich blocking ELISA, using a monoclonal antibody (MAb) against influenza A nucleoprotein (NP) was developed to detect antibodies against influenza. Collections of serum samples were obtained from human and various animal species. All influenza A subtypes induced antibodies against hemagglutinins and NP. A close correlation between titers of the hemagglutination inhibition (HI) test and the NP-ELISA was seen. Antibodies against influenza NP were demonstrated in serum samples from humans, ferrets, swine, horses, chickens, ducks, guinea pigs, mice, and seals. The serum samples were collected at intervals during prospective epidemiological studies, from experimental and natural infections, and vaccination studies. The decline of maternal antibodies was studied in swine and horses. The NP-ELISA enables rapid serological diagnosis and is suited for influenza A antibody screening, especially in species which harbor several influenza subtypes. The HI and neuraminidase inhibition tests, however, must still be used for subtyping.
Introduction
Influenza serotypes A, B and C are defined by the antigenic differences of their nucleoprotein (NP) and matrix protein. In animal species, influenza A viruses are most prevalent and are further grouped into different subtypes according to their specific hemagglutinin (H) and neuraminidase (N) surface proteins. The NP of influenza viruses was thought to be stable, but studies with monoclonal antibodies (MAb) have detected point mutations and reassortment of the NP genes of different influenza A strains [5, 19, 27] . The genomic variability may explain differences in host specificity between strains of the same HN subtype [3, 20] . Comparison of genomic NP sequences of H10 strains recovered from mink and chickens, however, showed constant regions [15] .
Previously we described a double antibody sandwich (DAS) enzyme-linked immunosorbent assay (ELISA) for influenza A antigen detection using one MAb directed to a conserved antigenic determinant of NP of influenza A viruses [21] . Using the same MAb, we developed a blocking DAS-ELISA to detect antibodies raised by influenza A NP in various animal species (NP-ELISA).
In influenza diagnostics by ELISA, plates are usually coated with antibodies against hemagglutinins and the conjugates are directed against immunoglobulins [1, 4, 6, 8, 12, 22, 23, 25] . We used one MAb directed against influenza NP for coating and for preparing the conjugate. Serum samples collected from humans, ferrets, swine, horses, chickens, ducks, mice and seals were used to compare the NP-ELISA with the hemagglutination inhibition (HI) test. The serum samples were collected at intervals during prospective epidemiological studies, experimental and natural infections, and vaccination studies. In addition, samples were collected from mares and sows and their offspring to study the decline of maternal antibodies.
Materials and methods

Serum samples
Ferrets 15 ferrets were intranasally infected with various strains of influenza serotypes A and B, described in Table 1 . Five ferrets were not infected and served as negative controls. Serum samples were collected 2 to 3 weeks post infection.
Humans 55 human volunteers were intramuscularly vaccinated with three commercial trivalent vaccines containing A/Leningrad/360/86 (H3N2), A/Singapore/6/86 (H1N1), and B/Ann Arbor/I/86. A subunit (Duphar), a whole virus (Duphar), and a split-virus vaccine (Rh6ne M6rieux) were compared. Serum samples were collected before and 3 weeks post vaccination.
Swine
Two specified-pathogen-free (SPF) pigs were twice intranasally infected with A/swine/ Netherlands/25/80 (H 1N 1) and another two with A/swine/Netherlands/1/85 (H3N2). Serum samples were collected before inoculation and at 11, 18, 22 and 29 days post infection, and again at 7 and 21 days after the booster infection.
During a prospective study, serum samples were collected at 3-week intervals in a closed farm with breeding stock and fattening pigs. A group of 16 fattening pigs of this farm was tested by NP-ELISA after the HI test had revealed a subclinical infection with an H3N2 subtype.
Six groups of 29 conventional pigs were twice vaccinated with six different experimental vaccines, which contained different concentrations of purified influenza A whole virus antigen of subtype H1N1 (A/swine/Netherlands/25/80), 8 to 12gg hemagglutinin, and subtype H3N2 (A/Philippines/2/82 and A/Port Chalmers/i/73), respectively 4 to 6 gg hemagglutinin. The experimental vaccines were all formulated as an oil-in-water emulsion. The HI and ELISA titers were compared 2weeks post vaccination. A sow which was vaccinated twice with a vaccine containing the same H1N1 and H3N2 subtypes, received a booster vaccination 2 weeks before parturition. Serum samples of her litter of twelve piglets were collected at 2, 7, 8, and 10.5 weeks of age.
Horses
Ten foals were serologically monitored by HI test and NP-ELISA from the day of parturition until 5.5 months of age. Their dams had been routinely vaccinated twice a year with inactivated vaccines, containing A/equi/Prague/1/56 (H1N7), A/equi/Miami/1/63 (H3N8), and A/equi/Kentucky/81(H3N8) and had received the same vaccine 4 to 6weeks before parturition.
Chickens, ducks, guinea pigs, mice, and seals Nine SPF chickens were twice intramuscularly infected with 104EIDs0 A/duck/Ukraine/l/ 63 (H3N8), at day 1 and at day 35. Serum samples were collected two weeks after the first (day 14) and three weeks after the second vaccination (day 56).
65 sera were collected from wild ducks during the hunting season and from materials submitted to the Regional Animal Health Centre in Velp and our laboratory. Sera were screened in the NP-ELISA at dilution of 1:2.
16 guinea pigs were vaccinated twice at 3-week intervals with eight experimental vaccines to be used in horses. These vaccines were of three different types: 5 whole virus, 2 subunit, and one iscom (immunostimulating-complex) vaccine, which all contained viral components of the subtypes HTN7 and H3N8. The guinea pigs received 1% of the dosage that is given to horses. The HI and ELISA titers were compared at 2 weeks after the second vaccination.
To produce MAb against influenza NP, four BALB/c mice were intraperitoneally inoculated at 4-week intervals with 100 gg density gradient-purified A/chicken/Netherlands/ 85 (H1N1) in incomplete Freund's adjuvant, 50 gg A/Hongkong/68 (H3N2) in complete Freund's adjuvant, and intravenously with 50 gg A/duck/Ireland/84 (H5NS). Serum samples were collected 10weeks after the second booster.
We received a large collection of serum samples collected from seals and sealions: 757 serum samples were collected from seals in the North Sea during the 1988 epidemic attributed to a Morbilli virus [13] , and 338 serum samples were collected from seals and sealions in the Beringsea between 1978 and 1988. The sera were screened in the NP-ELISA in a dilution of 1:20. Serum samples that were positive in the NP-ELISA were tested in the HI test after treatment with Vibrio Cholerae filtrate and kaolin.
Serological techniques
ELISA
Monoctonal antibody, conjugate, and substrate. A hybridoma cell line that produces MAb against a conserved antigenic NP determinant of influenza A was obtained from the American Type Culture Collection (ATCC No.: HB65, H16-L10-4R5). This hybridoma was originally established by Yewdell et al. [28] who used influenza A/WSN/33 (H1N1) and A/PR8/34 (HIN1) to immunize BALB/c mice. This MAb was used for coating of the ELISA plates (Costar Cat. No. 3590) and for preparing the conjugate with horseradish peroxidase; 3,3, 5,5 tetramethylbenzidine (TMB) (Sigma Cat. No. T2885) was used as substrate. The techniques used for these manipulations have been described before [21] .
Antigen. Influenza A/Japan/305/57 (H2N2) was grown in 11-day-old embryonated eggs of SPF chickens. After 4 days, the allantoic fluid was harvested and centrifuged at 2000 rpm for 10 rain. To disrupt the virus particles, the clarified allantoic fluid was treated with equal amounts of 1% Nonidet P40 in phosphate-buffered saline (PBS) for t h at 37 °C.
NP-ELISA
Polystyrene 96-well microtiter plates were coated with MAb HB65 directed against NP of influenza A in a dilution of 1:2,000 in 100 gl coating buffer for 18 h at 37 °C. The coating buffer was prepared by adding Na2CO3, 5.28 g/1 to NaHCO3, 4.2 g/1 until a pH of 9.6 was obtained. The plates were washed two times with 0.05% Tween 80 in tap-water and were sealed after 100 gl of 87% glycerol was added. The plates could be stored at 4 °C for several months.
The NP-ELISA was performed as follows. After washing of the plates, 50 ~tl of the undiluted test serum was mixed in the test wells with 50 gl of antigen diluted 1:10 in ELISA buffer. The ELISA buffer contained per liter: 59 g NaC1, 0.2 g KC1, 1.15 g Na2HPO4, 0.2 g KH2PO4, 0.05% Tween 80, and 4% calf serum (Gibco Ltd., Cat. No. 021-06010 M). After incubation at 37°C for I h, 100gl horseradish peroxidase conjugate, diluted 1:1000 in ELISA buffer, was added to each well and plates were further incubated at 37 °C for 1 h. After two washing steps, 100 gl of TMB substrate [211 was added and incubated at room temperature for 10min. The reaction was stopped by adding 100~tl H2SO 4 2M. The extinctions were measured at 450nm with a micro ELISA reader (Multiscan, Flow). A reduction of the extinction greater than 50% of the maximum extinction was considered positive. The maximum extinction was determined as the mean extinction of eight wells that were filled with ELISA buffer instead of serum. An equine hyperimmune serum was used as positive control.
Hemagglutination inhibition test
The HI tests were performed in three laboratories, basically according to standard procedures. The HI test used to detect antibodies in human and ferret sera was described in detail previously [11 a] . Before being tested in the HI test, all sera were treated with Vibrio Cholerae filtrate to reduce false-positive reactions. The serum samples from seals and sealions were also treated with kaolin.
Results
The NP-ELISA detected antibodies against influenza A nucleoprotein in all ten ferrets that were infected with human isolates of subtypes H 1 N1 and H3N2. Serum samples from influenza B-infected ferrets were negative in the ELISA. Hemagglutinating antibodies were detected in all infected ferrets at 2 to 3 weeks post infection (Table 1) . In a group of 19 human volunteers, mean NP-ELISA titers (mean = 83) were not increased by vaccination with hemagglutinin subunit vaccine, unlike mean HI antibody titers, which were. Vaccination with whole virus and split virus vaccines, however, resulted in an increase of NP-ELISA titers, from 77 to 107 and from 80 to 136, within a 3-week period. The split virus vaccine yielded the strongest antibody response as measured by both the HI test and NP-ELISA (Table 2) .
in pigs, both types of antibodies were induced after experimental infection with H1N1 and H3N2 subtypes ( Fig. 1 ) and after natural exposure to H3N2 (Fig. 2) . The HI response against experimental infection with H3N2 was stronger than against the H1N1 subtype. The NP-ELISA titers increased slowly after booster vaccination with both subtypes of swine influenza virus. The increase of NP-ELISA antibodies during the subclinical infection was as slow as after experimental exposure. The first indication of subclinical infection was HI No. of individuals vaccinated with an influenza subunit vaccine b Reciprocal of geometrical mean titer (GMT) ° Serum samples were collected after 3 weeks antibody in one pig, but at that time antibodies against NP were already detectable in eight pigs. Vaccination of swine with an inactivated vaccine containing H1N1 and H3N2 subtypes induced HI antibodies only after the booster vaccination. The NP-ELISA, however, detected antibodies against NP after the first vaccination (Fig. 3) . Thereafter, the mean titers of both types of antibodies were similar. Vaccination of groups of 29 pigs with six experimental influenza vaccines containing H1N1 and H3N2 subtypes yielded different HI and NP-ELISA titers at 35 days post infection (Fig. 4) . In contrast to titers measured during natural influenza infections (Fig. 2) , the mean NP-ELISA titers were higher than HI titers, but individual titers of both types of antibody differed greatly.
In 12 piglets studied, the two types of maternal antibodies showed a different rate of decline (Fig. 5) . At the age of 2 weeks, all of the piglets had the same HI and NP-ELISA titers as the sow had at parturition. At 7 weeks, HI antibodies were detected in three pigs only, and at 8 weeks in none. In contrast, antibodies against NP remained detectable in all piglets until the age of 10.5 weeks.
In horses, maternal antibodies were detected by both HI test and NP-ELISA and persisted in ten foals for 5.5 months (Fig. 6) . The decline of both types of maternal antibodies was parallel. The correlations between HI and NP-ELISA titers for subtypes H7N7 and H3N8 were 93% and 91%.
All nine chickens that were twice infected with influenza A/duck/Ukraine/ 1/63 (H3N8) developed antibodies as detected by both HI test and NP-ELISA (Table 3) . In wild ducks antibodies were detected by NP-ELISA in 15 out of 63 serum samples. 14 of these samples were also positive in the HI test. The following influenza H subtypes were detected by HI tests: H1, H2, H4, H5, H6, H9, H10, and H 12 ( Table 4) .
The ten guinea pigs, which had been twice vaccinated with five experimental vaccines containing H7N7 and H3N8 subtypes, had a seroresponse in both Serum samples from sealions that were positive in the NP-ELISA were all negative in HI tests tests; the six guinea pigs vaccinated with experimental hemagglutinin subunit and iscom vaccines developed HI antibodies only.
All four BALB/c mice, which were subsequently infected with H 1N1, H3N2, and H5N8 subtypes, to obtain monoclonal antibodies directed against influenza NP, developed antibodies detectable by HI test and NP-ELISA. The MAbs against influenza NP thus obtained were less suited to develop a NP-ELISA than MAb HB65 received from ATCC.
Influenza antibodies were detected by NP-ELISA screening in three serum samples from seals in the Northsea and in 43 samples from seals and sealions in the Beringsea. Respectively, one and 10 of the NP-ELISA-positive samples from seals inhibited hemagglutination when tested against 12 H subtypes of influenza virus. The HI antibodies were directed against subtypes H1, H3, H4, H7, H12 (Table 5) . HI antibodies were not detected in the NP-ELISA-positive sera from sealions.
Discussion
The NP-ELISA detected antibodies induced by influenza A infections in humans, ferrets, swine, horses, chickens, ducks, guinea pigs, mice, and seals. A MAb directed against a conserved influenza A nucleoprotein epitope also reacted with numerous influenza A subtypes from various sources [21] and was very useful in developing a broad-spectrum blocking DAS-ELISA to detect antibodies. Because we used the same MAb to coat ELISA plates and prepare the conjugate, a high specificity was achieved [14] . A high sensitivity was obtained because we used disrupted antigens of a human subtype that showed the strongest binding in DAS-ELISA [21] .
In general, antibodies detected by the HI test and NP-ELISA appeared in association with each other. After natural influenza virus infections in ferrets, swine, and chickens, antibody titers detected in the HI test were higher than those directed against NP. The titers of the two types of antibody cannot be compared, however, because the tests detect different types of antibody and have different sensitivities. Vaccination of swine and chickens, however, induced a more consistent and earlier antibody response against NP than against hemmagglutinins. As a result of vaccine preparation NP antigens apparently become better exposed. The differences between the six swine influenza vaccines (Fig. 4) were probably caused by the different amounts of influenza antigens incorporated into them and to the various preparation techniques.
In the human population frequent influenza infections cause a natural booster effect by repeated stimulation of antibodies directed against proteins which during evolution remained conserved among the various strains of influenza A viruses. The humoral immune response against nucleoproteins seems not affected by antigenic shift or drift. Antigen presentation of the NP is improved in the split virus vaccines because the influenza virus is disrupted during the preparation of the vaccine. This improvement was demonstrated by higher NP-ELISA titers in those human volunteers that were vaccinated with the split virus vaccine. Of course, the NP-ELISA titers were unaltered after vaccination with hemagglutinin subunit vaccine, but these were increased by vaccination with whole virus and split virus vaccines. These titers, however, increased only minimally, probably because of the presence of pre-existing antibodies directed against NP.
Recently, Rott and Klenk reviewed the prevalence of the different H subtypes of influenza A viruses in humans and animals [17] . They reported that subtype H3 had been found in humans, swine, horses, and birds; H12 was found only in birds. By using the NP-ELISA for screening and the HI test for subtyping, we not only confirmed the prevalence of various avian influenza subtypes in seals [7, 9, 18, 26 ], but we also observed for the first time that influenza subtype H12 circulates in seals. The discrepancy between NP-ELISA and HI results suggests that more than the known 13 H subtypes are prevalent in nature.
It has only recently been established that cytotoxic T lymphocytes are sensitized by NP in the immune response against influenza virus infection. The cytotoxic T lymphocyte response promotes the clearance of virus and recovery, but does not prevent infection [24, 28, 30] . Cytotoxic T cells may recognize both subtype-specific and cross-reactive determinants of NP. Immunization of mice with NP purified from the recombinant influenza virus X31 protected them against the PR8 strain [291. Transfer studies showed that stimulated cytotoxic T cells protect animals against lethal challenge, but that in vivoactivated cells fail to move to the lungs [2] . It is likely that B-cell immunity against hemagglutinin is enhanced by T-helper functions stimulated by NP.
Pigs with maternal antibodies against NP had a weaker HI response than those without. It is of interest to study whether the antibody responses against different structural proteins of influenza virus are somehow associated. This might be of importance for the timing of the first vaccination in foals and piglets.
In conclusion, like the DAS-ELISA for antigen detection [21] , the NP-ELISA can be used to rapidly differentiate between influenza and Aujeszky's disease in swine, and between influenza and Newcastle disease in fowl. The NP-ELISA is particularly suited to epidemiological screening of animal species that harbor various influenza A subtypes and for the diagnosis in those species to which no vaccines are routinely administered. The HI and neuraminidase inhibition tests, however, which require pre-treatment to eliminate nonspecific reactions, are still necessary for subtyping.
